On the contrary; I’m not angry at all. Ther s no
Post# of 11802
In this instance, I have full faith in the IP, the product, development, the FDA. The *only* problem... this is factual, if you attempt to deny or redirect this, it will be obvious you’re dealing as a pumper and not an investor interested in facts... is “deals” that are PR’d by management that evaporate into thin air. It’s a pattern. It’s not a one time phenomenon. So being as it’s the only issue, and it arises from management, what would you suggest? Ignore it? Ignore facts?